FDA Drug Shortages

Current and Resolved Drug Shortages and Discontinuations Reported to FDA

Start Over | Back to Previous Screen

Sodium Bicarbonate Injection
Status: Discontinuation
»Therapeutic Categories: Endocrinology/Metabolism; Gastroenterology; Pediatric

Athenex Pharmaceutical Division, LLC (Athenex) (Revised 06/07/2021)

Company Contact Information:

Presentation Posting Date Related Information
Sodium Bicarbonate Injection, 8.4% (1mEq/mL), 10mL per vial, 10 vials per carton (NDC 71456-001-01) 06/07/2021

Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English